These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 28747226)
1. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study. Falk Delgado A; Falk Delgado A Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226 [TBL] [Abstract][Full Text] [Related]
2. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis. Falk Delgado A; Falk Delgado A Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317 [TBL] [Abstract][Full Text] [Related]
3. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523 [TBL] [Abstract][Full Text] [Related]
4. Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials. Leite ETT; Moraes FY; Marta GN; Taunk NK; Vieira MTL; Hanna SA; Silva JLF; Carvalho HA Breast; 2017 Jun; 33():29-33. PubMed ID: 28273553 [TBL] [Abstract][Full Text] [Related]
5. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Boscardin WJ; Keyhani S BMJ; 2017 Jan; 356():i6770. PubMed ID: 28096109 [TBL] [Abstract][Full Text] [Related]
6. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
7. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey. Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186 [TBL] [Abstract][Full Text] [Related]
8. Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials. Khan NA; Nguyen CL; Khawar T; Spencer H; Torralba KD Rheumatology (Oxford); 2019 May; 58(5):776-785. PubMed ID: 30535001 [TBL] [Abstract][Full Text] [Related]
10. Positive association between conflicts of interest and reporting of positive results in randomized clinical trials in dentistry. Brignardello-Petersen R; Carrasco-Labra A; Yanine N; Ulloa C; Araya I; Pintor F; Villanueva J; Cornejo-Ovalle M J Am Dent Assoc; 2013; 144(10):1165-70. PubMed ID: 24080933 [TBL] [Abstract][Full Text] [Related]
11. Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals. Bridoux V; Moutel G; Schwarz L; Michot F; Herve C; Tuech JJ World J Surg; 2014 Oct; 38(10):2487-93. PubMed ID: 24824646 [TBL] [Abstract][Full Text] [Related]
12. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals. Grey P; Grey A; Bolland MJ Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636 [TBL] [Abstract][Full Text] [Related]
13. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. Aneja A; Esquitin R; Shah K; Iyengar R; Nisenbaum R; Melo M; Matthewkutty S; Sethi SS; Mamdani M; Farkouh ME J Am Coll Cardiol; 2013 Mar; 61(11):1137-43. PubMed ID: 23395075 [TBL] [Abstract][Full Text] [Related]
14. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial. Buffel du Vaure C; Boutron I; Perrodeau E; Ravaud P BMC Med; 2014 Apr; 12():69. PubMed ID: 24779384 [TBL] [Abstract][Full Text] [Related]
15. Controversies surrounding authorship of manuscripts by industry employees: academic and industry perspectives. Smilowitz NR; Ferguson JJ; Weisz G EuroIntervention; 2018 Mar; 13(16):1967-1974. PubMed ID: 29278351 [TBL] [Abstract][Full Text] [Related]
16. Assessment of self-reported financial conflicts of interest in vascular surgery studies. Tian T; Shah AY; Darling J; Zaepfel C; Chatterjee A; Iafrati M; Salehi P J Vasc Surg; 2021 Dec; 74(6):2047-2053. PubMed ID: 34171423 [TBL] [Abstract][Full Text] [Related]
17. Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials. Moraes FY; Mendez LC; Taunk NK; Raman S; Suh JH; Souhami L; Slotman B; Weltman E; Spratt DE; Berlin A; Marta GN J Neurooncol; 2018 Feb; 136(3):585-593. PubMed ID: 29164521 [TBL] [Abstract][Full Text] [Related]
18. Conflict of interest reporting in dentistry randomized controlled trials: a systematic review. Beyari MM; Hak A; Li CS; Lamfon HA J Evid Based Dent Pract; 2014 Dec; 14(4):158-64. PubMed ID: 25488864 [TBL] [Abstract][Full Text] [Related]
19. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey. Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA J Clin Epidemiol; 2017 Jul; 87():78-86. PubMed ID: 28412465 [TBL] [Abstract][Full Text] [Related]
20. Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Bariani GM; de Celis Ferrari AC; Hoff PM; Krzyzanowska MK; Riechelmann RP J Clin Oncol; 2013 Jun; 31(18):2289-95. PubMed ID: 23630201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]